MaxCyte Earnings Preview
Portfolio Pulse from Benzinga Insights
MaxCyte (NASDAQ:MXCT) is scheduled to release its quarterly earnings report on March 12, 2024, with analysts expecting an EPS of $-0.07. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter's miss resulting in a 3.28% drop. Shares are currently trading at $3.94, down 2.81% over the last year. Investors will be closely watching for not only the earnings results but also the company's guidance for future growth.
March 11, 2024 | 3:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
MaxCyte is expected to report an EPS of $-0.07 for the upcoming quarter. Historical data shows stock price sensitivity to earnings performance and guidance.
Given MaxCyte's historical stock price sensitivity to earnings performance and guidance, the upcoming earnings report could have a neutral to potentially positive impact if the company beats the EPS estimate and provides positive future guidance. However, the recent trend of stock price decline suggests investor caution.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100